insights_auto
Why is OCUL up 3.87%?
Dive Deeperchevron_right
OCUL:NASDAQ
Ocular Therapeutix Inc
US$6.85
arrow_upward
+3.87%(+0.26) 1D
US$6.77
arrow_downward
-1.17% (-0.080)bedtimeAfter hours
Closed: ኖቬም 9, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCUL...
Open
US$6.25
High
US$6.87
Low
US$6.05
Mkt. cap
1.50 ቢ
Avg. vol.
3.64 ሚ
Volume
0.00
52-wk high
US$16.44
52-wk low
US$6.00
EPS
-US$1.41
Beta
1.22
Shares outstanding
219.62 ሚ
No. of employees
325
Open
US$6.25
High
US$6.87
Low
US$6.05
Mkt. cap
1.50 ቢ
Avg. vol.
3.64 ሚ
Volume
0.00
52-wk high
US$16.44
52-wk low
US$6.00
EPS
-US$1.41
Beta
1.22
Shares outstanding
219.62 ሚ
No. of employees
325
News stories
From web sources and news partners
GuruFocus
·
ከ26 ደቂቃዎች በፊት
OCUL SWOT Analysis: Financial Challenges and Growth Potential Re
VisionMonday.com
·
ከ34 ደቂቃዎች በፊት
Ocular Therapeutix Reports Third Quarter 2026 Financial Results, Provides Business Update
Yahoo Finance Singapore
·
ከ14 ሰዓቶች በፊት
Ocular Therapeutix falls on third quarter earnings miss
TradingView
·
ከ14 ሰዓቶች በፊት
OCUL: SOL-1 results underpin a planned Q4 NDA as investment and launch preparations advance
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, ማሣቹሰትስ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryPharmaceutical industry
Websiteocutx.com